Tolfedine Tablets 60 mg

NSAIDS can cause inhibition of phagocytosis and hence in the treatment of
inflammatory conditions associated with bacterial infections appropriate concurrent
antimicrobial therapy should be instigated.
In dogs, long term treatment of over 3 months duration should be under regular
veterinary supervision. In particular, dogs with hepatic insufficiency should be closely
monitored.

Special precautions for safe use in the target species:
Use in animals less than 6 weeks of age, or in aged animals, may involve additional
risk. If such a use cannot be avoided, animals may require a reduced dosage and
careful clinical management.
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a
potential risk of increased renal toxicity.
Concurrent administration of potential nephrotoxic drugs should be avoided.
It is preferable that the product is not administered to animals undergoing general
anaesthesia until fully recovered.
Do not exceed the prescribed dosage or duration of treatment.
Animals suffering from a chronic renal insufficiency and requiring an anti-
inflammatory treatment may be treated with tolfenamic acid without requiring an
adjustment of the dosage. However, the use of this product is contraindicated in
acute cases of renal insufficiency.
In case of undesirable effects (anorexia, vomiting, diarrhoea, presence of blood in
faeces) occurring during the treatment, your veterinarian should be contacted for
advice.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
In case of accidental contact with eyes, wash with plenty of water.
Special precautions for the protection of the environment:
Not applicable.